FEATURED BLOGS
Mar 03, 2021
"2020 will be a year we at CancerLinQ look back on with mixed emotion because, in the midst of the pandemic, we achieved a momentous milestone," said Dr. Danielle Potter.
Mar 02, 2021
"Leading right now means helping team members adapt to the losses that all have experienced and supporting them with more than exhortation and reassurance," writes Dr. Mark E. Robson.
Feb 18, 2021
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Feb 11, 2021
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
Feb 03, 2021
"We honor this 21st World Cancer Day with a continuing commitment to tackling challenges in cancer care together, because our collective actions matter in advancing science, delivering care, and...
Feb 01, 2021
I believe that we are emerging from this past year strengthened and positioned to make an even greater impact in the future.
Jan 28, 2021
Meeyoung Lee and I discuss expectations, goals, realism, and hope when recommending a phase I clinical trial to a patient with cancer.

Advertisement

Latest Comments & Discussions


Paul Goott
Feb 17, 2021
Amazing to read and learn about the progress in therapies and treatments as well raising the call for more investment and...

Philip J. Stella, MD, FASCO
Jan 30, 2021
    I remember Joe Simone fondly as a titan of quality care in Oncology. Back in 2000 when we were both on ASCO's board we...

Ahmed Mohamed Badheeb, MD
Jan 28, 2021
Well done! Dr. Atlal, I think oncology clinicians have an important role in identifying symptoms, acquiring resilience skills, and...

Christopher M. Rose, FACR, FASTRO, MD
Jan 26, 2021
Dr. Simone was one of our giants. After his seminal contributions to the management of pediatric ALL, his stewardship of the original...

Digital India
Jan 21, 2021
Nice post, Thanks for this information. I really appreciate the kind of topics you post here. Thanks for sharing with us a great...

Pages

Most Read

Much of the progress of the past 5 decades was catalyzed by the National Cancer Act, signed into law by President Richard Nixon in December 1971.
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
"Leading right now means helping team members adapt to the losses that all have experienced and supporting them with more than exhortation and reassurance," writes Dr. Mark E. Robson.
Meeyoung Lee and I discuss expectations, goals, realism, and hope when recommending a phase I clinical trial to a patient with cancer.

Tweets from ASCO

Tweets from Oncology Community